237 related articles for article (PubMed ID: 27321573)
1. Baeyer-Villiger Monooxygenases EthA and MymA Are Required for Activation of Replicating and Non-replicating Mycobacterium tuberculosis Inhibitors.
Grant SS; Wellington S; Kawate T; Desjardins CA; Silvis MR; Wivagg C; Thompson M; Gordon K; Kazyanskaya E; Nietupski R; Haseley N; Iwase N; Earl AM; Fitzgerald M; Hung DT
Cell Chem Biol; 2016 Jun; 23(6):666-77. PubMed ID: 27321573
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatic Mining and Structure-Activity Profiling of Baeyer-Villiger Monooxygenases from Mycobacterium tuberculosis.
Tomas N; Leonelli D; Campoy M; Marthey S; Le NH; Rengel D; Martin V; Pál A; Korduláková J; Eynard N; Guillet V; Mourey L; Daffé M; Lemassu A; André G; Marrakchi H
mSphere; 2022 Apr; 7(2):e0048221. PubMed ID: 35296143
[TBL] [Abstract][Full Text] [Related]
3. Whole-Transcriptome and -Genome Analysis of Extensively Drug-Resistant Mycobacterium tuberculosis Clinical Isolates Identifies Downregulation of
de Welzen L; Eldholm V; Maharaj K; Manson AL; Earl AM; Pym AS
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28993337
[TBL] [Abstract][Full Text] [Related]
4. Bacterial Genome-Wide Association Identifies Novel Factors That Contribute to Ethionamide and Prothionamide Susceptibility in Mycobacterium tuberculosis.
Hicks ND; Carey AF; Yang J; Zhao Y; Fortune SM
mBio; 2019 Apr; 10(2):. PubMed ID: 31015328
[TBL] [Abstract][Full Text] [Related]
5. Efficient analoging around ethionamide to explore thioamides bioactivation pathways triggered by boosters in Mycobacterium tuberculosis.
Prieri M; Frita R; Probst N; Sournia-Saquet A; Bourotte M; Déprez B; Baulard AR; Willand N
Eur J Med Chem; 2018 Nov; 159():35-46. PubMed ID: 30268015
[TBL] [Abstract][Full Text] [Related]
6. The small-molecule SMARt751 reverses
Flipo M; Frita R; Bourotte M; Martínez-Martínez MS; Boesche M; Boyle GW; Derimanov G; Drewes G; Gamallo P; Ghidelli-Disse S; Gresham S; Jiménez E; de Mercado J; Pérez-Herrán E; Porras-De Francisco E; Rullas J; Casado P; Leroux F; Piveteau C; Kiass M; Mathys V; Soetaert K; Megalizzi V; Tanina A; Wintjens R; Antoine R; Brodin P; Delorme V; Moune M; Djaout K; Slupek S; Kemmer C; Gitzinger M; Ballell L; Mendoza-Losana A; Lociuro S; Deprez B; Barros-Aguirre D; Remuiñán MJ; Willand N; Baulard AR
Sci Transl Med; 2022 May; 14(643):eaaz6280. PubMed ID: 35507672
[TBL] [Abstract][Full Text] [Related]
7. Phenylethyl butyrate enhances the potency of second-line drugs against clinical isolates of Mycobacterium tuberculosis.
Grau T; Selchow P; Tigges M; Burri R; Gitzinger M; Böttger EC; Fussenegger M; Sander P
Antimicrob Agents Chemother; 2012 Feb; 56(2):1142-5. PubMed ID: 22106218
[TBL] [Abstract][Full Text] [Related]
8. Integrated analysis of ethionamide resistance loci in Mycobacterium tuberculosis clinical isolates.
da Silva DA; Ferreira NV; Rego AM; Barbosa PCP; Machado RF; Pimentel A; Dos Reis LM; de Pina LC; Redner P; Caldas PCS; Fandinho-Montes FCO; Borga L; Leite SP; da Rocha JL; Bastos LS; Ramos JP; Degrave WM; Antunes LCM; Galvão TC
Tuberculosis (Edinb); 2018 Dec; 113():163-174. PubMed ID: 30514498
[TBL] [Abstract][Full Text] [Related]
9. EthR, a repressor of the TetR/CamR family implicated in ethionamide resistance in mycobacteria, octamerizes cooperatively on its operator.
Engohang-Ndong J; Baillat D; Aumercier M; Bellefontaine F; Besra GS; Locht C; Baulard AR
Mol Microbiol; 2004 Jan; 51(1):175-88. PubMed ID: 14651620
[TBL] [Abstract][Full Text] [Related]
10. Mycothiol biosynthesis is essential for ethionamide susceptibility in Mycobacterium tuberculosis.
Vilchèze C; Av-Gay Y; Attarian R; Liu Z; Hazbón MH; Colangeli R; Chen B; Liu W; Alland D; Sacchettini JC; Jacobs WR
Mol Microbiol; 2008 Sep; 69(5):1316-29. PubMed ID: 18651841
[TBL] [Abstract][Full Text] [Related]
11. Genotypic Analysis of Genes Associated with Independent Resistance and Cross-Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis Clinical Isolates.
Rueda J; Realpe T; Mejia GI; Zapata E; Rozo JC; Ferro BE; Robledo J
Antimicrob Agents Chemother; 2015 Dec; 59(12):7805-10. PubMed ID: 26369965
[TBL] [Abstract][Full Text] [Related]
12. Ethionamide biomimetic activation and an unprecedented mechanism for its conversion into active and non-active metabolites.
Laborde J; Deraeve C; Duhayon C; Pratviel G; Bernardes-Génisson V
Org Biomol Chem; 2016 Sep; 14(37):8848-8858. PubMed ID: 27714216
[TBL] [Abstract][Full Text] [Related]
13. The prodrug activator EtaA from Mycobacterium tuberculosis is a Baeyer-Villiger monooxygenase.
Fraaije MW; Kamerbeek NM; Heidekamp AJ; Fortin R; Janssen DB
J Biol Chem; 2004 Jan; 279(5):3354-60. PubMed ID: 14610090
[TBL] [Abstract][Full Text] [Related]
14. Structural and docking studies of potent ethionamide boosters.
Tatum NJ; Villemagne B; Willand N; Deprez B; Liebeschuetz JW; Baulard AR; Pohl E
Acta Crystallogr C; 2013 Nov; 69(Pt 11):1243-50. PubMed ID: 24192167
[TBL] [Abstract][Full Text] [Related]
15. Isoxyl activation is required for bacteriostatic activity against Mycobacterium tuberculosis.
Korduláková J; Janin YL; Liav A; Barilone N; Dos Vultos T; Rauzier J; Brennan PJ; Gicquel B; Jackson M
Antimicrob Agents Chemother; 2007 Nov; 51(11):3824-9. PubMed ID: 17785510
[TBL] [Abstract][Full Text] [Related]
16. Identification of a novel Baeyer-Villiger monooxygenase from Acinetobacter radioresistens: close relationship to the Mycobacterium tuberculosis prodrug activator EtaA.
Minerdi D; Zgrablic I; Sadeghi SJ; Gilardi G
Microb Biotechnol; 2012 Nov; 5(6):700-16. PubMed ID: 22862894
[TBL] [Abstract][Full Text] [Related]
17. Analogues of ethionamide, a drug used for multidrug-resistant tuberculosis, exhibit potent inhibition of tyrosinase.
Choi J; Park SJ; Jee JG
Eur J Med Chem; 2015 Dec; 106():157-66. PubMed ID: 26544630
[TBL] [Abstract][Full Text] [Related]
18. Mutation in Eth A protein of Mycobacterium tuberculosis conferred drug tolerance against enthinoamide in Mycobacterium smegmatis mc
Anand PK; Kumar A; Saini A; Kaur J
Comput Biol Chem; 2022 Jun; 98():107677. PubMed ID: 35397466
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a new Baeyer-Villiger monooxygenase and conversion to a solely N-or S-oxidizing enzyme by a single R292 mutation.
Catucci G; Zgrablic I; Lanciani F; Valetti F; Minerdi D; Ballou DP; Gilardi G; Sadeghi SJ
Biochim Biophys Acta; 2016 Sep; 1864(9):1177-1187. PubMed ID: 27344049
[TBL] [Abstract][Full Text] [Related]
20. [GenoType MTBDR plus 1.0® for the detection of cross-resistance between isoniazide and ethionamide in isolates of multidrug-resistant Mycobacterium tuberculosis].
Rueda J; Realpe T; Mejía G; Zapata E; Robledo J
Biomedica; 2015; 35(4):541-8. PubMed ID: 26844443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
